This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

Amendment to Enlarge Phase 3 LEVEL Study, Increasing Statistical Powering, Accepted by FDA, Expected to be Fully Enrolled Around Year End 2025. Agreement by FDA to Initiate Second ...

A breakthrough non-opioid drug could change fibromyalgia treatment forever--investors are piling in ahead of the FDA decision ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

Tenax Therapeutics (TENX) announced the U.S. Food and Drug Administration has completed their review of Tenax Therapeutics’ updated Phase 3 ...